Adalimumab, a Tumor Necrosis Factor Inhibitor, Is Effective for Severe Childhood Plaque Psoriasis

Summary and Comment |
May 16, 2017

Adalimumab, a Tumor Necrosis Factor Inhibitor, Is Effective for Severe Childhood Plaque Psoriasis